
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
Keywords: 2-CdA; 2-chlorodeoxyadenosine; ADC; antibody-drug conjugate; ALCL; anaplastic large cell lymphoma; ANC; absolute neutrophil count; ASM; aggressive systemic mastocytosis; BM; bone marrow; CT; computed tomography; ECNM; European Competence Network on Mastoc